Top Markets
Coin of the day
LadRx Corporation LadRx Corporation

LadRx Corporation

LADX
Clasificación en acciones #42092
LadRx Corporation, a biopharmaceutical company, engages in research and... LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.
Precio por acción
$0.01
Última sincronización: 2026-07-20
Capitalización bursátil
$4.95K
Cambio (1 día)
0.00%
Cambio (1 año)
-98.46%
País
US
Comercio LadRx Corporation (LADX)

Categoría

Historial de desdoblamientos de acciones de LadRx Corporation (LADX)
La acción LadRx Corporation (símbolo: LADX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 13, 2026.
Una acción LADX comprada antes de Aug 13, 2026 equivaldría hoy a 0 acciones LADX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR